CEL-SCI Corporation CVM

AF is Trumps nephew. It’s a family trait.

Nothing really has changed. Original PIII data had more than enough efficacy given zero toxicity and orphan drug. COVID unmasked corrupt nature of FDA. This is about protecting the franchise of Keytruda. Delays have further lined pockets of big pharma. I still think Geert may be part of this scenario. MK should have been approved months ago.

Look at the bump in CVM calls

Geert should have been fired long ago.
How many years did they lose with the company he hired to oversee testing initially? Studies finally show efficacy with 0 toxicity yet no approval. Why even have a BOD?

. Consequently, in order to stimulate product development and innovation, Congress in 1984 enacted Title II of the Drug Price Competition and Patent Term Restoration Act (Public Law 98-417) to extend patent life to compensate patent holders for marketing time lost while developing the product and awaiting government approval. Title II of the Act created a program whereby patent holders whose patents claim a human drug product, medical device, food additive or color additive could recoup some of the lost patent time.

MK would be classified as an orphan drug.
It treats a condition with no real new types of therapy in decades and - importantly - has ZERO toxicity. There is already enough data for approval for such a drug.. Companies like Merck most likely have franchise drugs that Keytruda in H&N cancer trials. The FDA is being bought off to protect such franchise drugs. My question is has Geert been bought off as well. As soon as CVM is bled dry and sold to a big pharma company for $20/s, MK will amazingly get fast track approval. That’s a far cry from the $150-$200/sh a stand alone CVM would bring with approval.

MK would be classified as an orphan drug.
It treats a condition with no real new types of therapy in decades and - importantly - has ZERO toxicity. There is already enough data for approval for such a drug.. Companies like Merck most likely have franchise drugs that Keytruda in H&N cancer trials. The FDA is being bought off to protect such franchise drugs. My question is has Geert been bought off as well. As soon as CVM is bled dry and sold to a big pharma company for $20/s, MK will amazingly get fast track approval. That’s a far cry from the $150-$200/sh a stand alone CVM would bring with approval.

A vaccine that kills children gets approved but a drug that saves lives gets ignored. I keep telling you people the FDA is not about saving lives

https://www.igor-chudov.com?utm_source=navbar&utm_medium=web

Why isn’t Geert in front of a microphone touting his life saving drug? How can such an ineffective CEO last so long? This has been going on for over THIRTY YEARS!

If the FDA was about saving lives, they would never have demonized ivermectin nor would they still be pushing the COVID vaccine. MK will not be approved until it is submitted by BIG pharma. - not bc of the lives it will save - but bc of the money it will make.